SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000059478-16-000342
Filing Date
2016-04-14
Accepted
2016-04-14 19:35:05
Documents
1
Period of Report
2016-04-12

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_146067689367014.html 4/A  
1 FORM 4/A wf-form4a_146067689367014.xml 4/A 6422
  Complete submission text file 0000059478-16-000342.txt   9159
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Reporting) CIK: 0000059478 (see all company filings)

State of Incorp.: IN | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-37722 | Film No.: 161572886
SIC: 2834 Pharmaceutical Preparations

Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Reporting) CIK: 0001575852 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-37722 | Film No.: 161572885

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LILLY VENTURES FUND I, LLC 115 W. WASHINGTON STREET,STE 1680-SOUTH INDIANAPOLIS IN 46204
Business Address
Shanafelt Armen (Reporting) CIK: 0001656151 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37722 | Film No.: 161572884